共 34 条
- [21] Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid LeukemiaBLOOD, 2021, 138Stroopinsky, Dina论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAKoshy, Anita G.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USALiegel, Jessica J.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USANahas, Myrna论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USACheloni, Giulia论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAHauser, Joshua论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USATorres, Daniela论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USABindal, Poorva论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USARahimian, Maryam论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USABisharat, Lina论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAFraenkel, Paula论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Cambridge, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAYildirim, Ozlem论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Cambridge, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USABonnevaux, Helene论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Paris, France Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAGuerif, Stephane论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Paris, France Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAKufe, Donald论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Harvard Med Sch, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USARosenblatt, Jacalyn论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USAAvigan, David论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
- [22] A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent for the Treatment of Older Patients with Acute Myeloid Leukemia (AML)BLOOD, 2023, 142Zabaleta, Aintzane论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainMartin-Sanchez, Esperanza论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainBlanco, Laura论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainKim, Peter论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainBisht, Kamlesh论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainWang, Hongfang论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainVan de Velde, Helgi J.论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainJelinek, Tomas论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Ostrava, Dept Haematooncol, Ostrava, Czech Republic Fac Med, Ostrava, Czech Republic CCUN, CIMA, IdiSNA, CIBER ONC, Pamplona, Spain Univ Ostrava, Fac Sci, Ostrava, Czech Republic Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainSimoes, Catia论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainProsper, Felipe论文数: 0 引用数: 0 h-index: 0机构: Canc Ctr Clin Univ Navarra, CIMA, IDISNA, CIBER ONC, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainSan-Miguel, Jesus论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainMartinez-Cuadron, David论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ & Politecn La Fe, Valencia, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainMontesinos, Pau论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ & Politecn La Fe, Valencia, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, SpainPaiva, Bruno论文数: 0 引用数: 0 h-index: 0机构: Canc Ctr Clin Univ Navarra, CIMA, IDISNA, CIBER ONC, Pamplona, Spain Inst Invest Sanitaria Navarra IdiSNA, CIMA Pamplona Canc Ctr Clin Univ Navarra CCUN, CIMA, CIBER ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain
- [23] Characterization of a Novel Type of Mature CD4-Positive T-cell Leukemia that Primarily Involves Peripheral Blood and Bone MarrowLABORATORY INVESTIGATION, 2023, 103 (03) : S1131 - S1131Fang, Hong论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USABeird, Hannah论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAWang, Sa论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAIbrahim, Andrew论文数: 0 引用数: 0 h-index: 0机构: Texas Tech Univ Hlth Sci Ctr, Lubbock, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USATang, Zhenya论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAYou, M. James论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USALe, Nhi论文数: 0 引用数: 0 h-index: 0机构: Rice Univ, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAFutreal, Andrew论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAHu, Shimin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAYin, C. Cameron论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAThakral, Beenu论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAMedeiros, L. Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USAWang, Wei论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Houston, TX USA
- [24] Phase I study of CN201, a novel CD3xCD19 IgG4 bispecific antibody, in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemiaJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Wang, Ying论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaYin, Qingsong论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaRen, Jinhai论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaZhou, Hongsheng论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaGong, Tiejun论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaZhu, Feng论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaZhang, Xi论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaWen, Qin论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaMei, Heng论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaHuang, Wei论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaLi, Haiying论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R ChinaWang, Jianxiang论文数: 0 引用数: 0 h-index: 0机构: CAMS & PUMC, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
- [25] Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using Cross-Over-Dual-Variable-Domain (CODV) format for the treatment of acute myeloid leukemia (AML)CANCER RESEARCH, 2018, 78 (13)Bonnevaux, Helene论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceGuerif, Stephane论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceAlbrecht, Jana论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Berlin, Germany Sanofi R&D, Vitry Sur Seine, FranceJouannot, Erwan论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceBassinet, Laurent论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceVergezac, Agnes论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceBeil, Christian论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Berlin, Germany Sanofi R&D, Vitry Sur Seine, FranceLange, Christian论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Berlin, Germany Sanofi R&D, Vitry Sur Seine, FranceLeuschner, Wulf Dirk论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Berlin, Germany Sanofi R&D, Vitry Sur Seine, FranceCaron, Anne论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceAmara, Celine论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceBarriere, Cedric论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceSiavellis, Justine论文数: 0 引用数: 0 h-index: 0机构: INSERM, Paris, France Sanofi R&D, Vitry Sur Seine, FranceBardet, Valerie论文数: 0 引用数: 0 h-index: 0机构: INSERM, Paris, France Sanofi R&D, Vitry Sur Seine, FranceLuna, Ernesto论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur, Orlando, FL USA Sanofi R&D, Vitry Sur Seine, FranceDrake, Donald论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur, Orlando, FL USA Sanofi R&D, Vitry Sur Seine, FranceRao, Ercole论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Berlin, Germany Sanofi R&D, Vitry Sur Seine, FranceOprea, Corina论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceWonerow, Peter论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Berlin, Germany Sanofi R&D, Vitry Sur Seine, FranceCarrez, Chantal论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceBlanc, Veronique论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Vitry Sur Seine, France Sanofi R&D, Vitry Sur Seine, FranceHsu, Karl论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Sanofi R&D, Vitry Sur Seine, FranceWiederschain, Dmitri论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Sanofi R&D, Vitry Sur Seine, FranceFraenkel, Paula G.论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Cambridge, MA USA Sanofi R&D, Vitry Sur Seine, France
- [26] Optimal treatment strategy and prognostic analysis for hypopharyngeal squamous-cell carcinoma patients with T3-T4 or node-positive: A population-based studyEJSO, 2023, 49 (07): : 1162 - 1170Zheng, Linhui论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaFang, Sha论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaYe, Linfeng论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaCai, Wenqi论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaXiang, Wenbin论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaQi, Yan论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaWu, Huachao论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaYang, Chunqian论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaZhang, Runze论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaLiu, Yifeng论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaLiu, Yue论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaWu, Chaoyan论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Dept Integrated Tradit Chinese Med & Western Med, Wuhan 430071, Peoples R China 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R ChinaYu, Haijun论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Wuhan 430071, Peoples R China Hubei Key Lab Tumor Biol Behav, Wuhan 430071, Peoples R China 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Peoples R China
- [27] Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatmentONCOIMMUNOLOGY, 2021, 10 (01):Bonnevaux, Helene论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceGuerif, Stephane论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceAlbrecht, Jana论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceJouannot, Erwan论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceDe Gallier, Thibaud论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceBeil, Christian论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceLange, Christian论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceLeuschner, Wulf Dirk论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceSchneider, Marion论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceLemoine, Cendrine论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceCaron, Anne论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceAmara, Celine论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceBarriere, Cedric论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceSiavellis, Justine论文数: 0 引用数: 0 h-index: 0机构: Univ Versailles St Quentin, Hop Univ Paris Ile France Ouest, Paris, France Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France论文数: 引用数: h-index:机构:Luna, Ernesto论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur VaxDesign, Orlando, FL USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceAgrawal, Pankaj论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur VaxDesign, Orlando, FL USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceDrake, Donald R.论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur VaxDesign, Orlando, FL USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceRao, Ercole论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceWonerow, Peter论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceCarrez, Chantal论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceBlanc, Veronique论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceHsu, Karl论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceWiederschain, Dmitri论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceFraenkel, Paula G.论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, FranceVirone-Oddos, Angela论文数: 0 引用数: 0 h-index: 0机构: Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France Sanofi R&D, Frankfurt, Germany Sanofi R&D, Cambridge, MA USA Sanofi R&D, Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France
- [28] Evaluation of a Novel Human CD4+ CD25DIMFOXP3- T-Cell Population in Cancer Patients Undergoing Interleukin-2 TreatmentJOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 963 - 964Triplett, Todd A.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, MMI, Portland, OR 97201 USA Earle A Chiles Res Inst, Portland, OR USA Oregon Hlth & Sci Univ, MMI, Portland, OR 97201 USAWeinberg, Andrew论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, MMI, Portland, OR 97201 USA Earle A Chiles Res Inst, Portland, OR USA Oregon Hlth & Sci Univ, MMI, Portland, OR 97201 USA
- [29] Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3+ and CD8+ T Cells and Immune Checkpoints Expression but Gradually Leads to CD4+ T-Cell DepletionBLOOD, 2017, 130Palma, Marzia论文数: 0 引用数: 0 h-index: 0Heimersson, Kia论文数: 0 引用数: 0 h-index: 0Nasman-Glaser, Barbro论文数: 0 引用数: 0 h-index: 0Mellstedt, Hakan论文数: 0 引用数: 0 h-index: 0Osterborg, Anders论文数: 0 引用数: 0 h-index: 0
- [30] Epstein–Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21)International Journal of Hematology, 2015, 102 : 482 - 487Masakazu Higuchi论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineShoichi Sasaki论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineShin-ichiro Kawadoko论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineHikaru Uchiyama论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineTakaharu Yasui论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineTakashi Kamihira论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineKen-ichi Aoki论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineTakakazu Sasaguri论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineRyuji Nakano论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineAkihiko Uchiyama论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineTsuyoshi Muta论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal MedicineKoichi Ohshima论文数: 0 引用数: 0 h-index: 0机构: Japan Community Health Care Organization (JCHO) Kyushu Hospital,Department of Internal Medicine